Title,URL,Found,IS_PMC,IS_NOT_PREPRINT
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.,https://rupress.org/jem/article-pdf/220/5/e20221952/1449193/jem_20221952.pdf,1,False,True
Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.,http://insight.jci.org/articles/view/157347/files/pdf,1,False,True
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer.,https://rupress.org/jem/article-pdf/220/4/e20220729/1446847/jem_20220729.pdf,1,False,True
IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy.,http://www.jci.org/articles/view/161084/files/pdf,1,False,True
Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666.,https://www.nature.com/articles/s41416-022-02135-4.pdf,1,False,True
SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation.,https://www.nature.com/articles/s41392-023-01314-w.pdf,1,False,True
Engineered antibody cytokine chimera synergizes with DNA-launched nanoparticle vaccines to potentiate melanoma suppression in vivo.,https://europepmc.org/articles/PMC9997082?pdf=render,1,True,True
"Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition.",https://jpet.aspetjournals.org/content/jpet/early/2022/10/14/jpet.122.001255.full.pdf,0,False,True
Supplementation with α-ketoglutarate improved the efficacy of anti-PD1 melanoma treatment through epigenetic modulation of PD-L1.,https://www.nature.com/articles/s41419-023-05692-5.pdf,1,False,True
YAP-controlled MHC-I and CXCL10 expression potentiates antitumor immunity independently of IFNγ signaling,https://www.biorxiv.org/content/biorxiv/early/2023/02/25/2023.02.25.530003.full.pdf,0,False,False
UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer.,http://www.jci.org/articles/view/158352/files/pdf,1,False,True
"Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.",https://europepmc.org/articles/PMC9965856?pdf=render,1,True,True
Oxygen microcapsules improve immune checkpoint blockade by ameliorating hypoxia condition in pancreatic ductal adenocarcinoma.,,1,False,True
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas.,https://europepmc.org/articles/PMC9840362?pdf=render,1,True,True
Downregulation of phosphoserine phosphatase potentiates tumor immune environments to enhance immune checkpoint blockade therapy.,https://jitc.bmj.com/content/jitc/11/2/e005986.full.pdf,1,False,True
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.,https://europepmc.org/articles/PMC9880309?pdf=render,1,True,True
Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy.,https://europepmc.org/articles/PMC9872099?pdf=render,1,True,True
A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinoma.,https://europepmc.org/articles/PMC9845215?pdf=render,1,True,True
A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy.,https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-023-03875-4,1,False,True
Molecular Imaging of Oxygenation Changes during Immunotherapy in Combination with Paclitaxel in Triple Negative Breast Cancer.,https://www.mdpi.com/2227-9059/11/1/125/pdf?version=1672825548,1,False,True
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells.,https://europepmc.org/articles/PMC9682353?pdf=render,1,True,True
Across-cancer specific immune responses induced by nanovaccines or microvaccines to prevent different cancers and cancer metastasis.,https://europepmc.org/articles/PMC9682363?pdf=render,1,True,True
Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma.,https://www.mdpi.com/1422-0067/23/24/16132/pdf?version=1671606521,1,False,True
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells.,https://www.nature.com/articles/s41467-022-35469-x.pdf,1,False,True
Molecular profiling identifies distinct subtypes across TP53 mutant tumors.,http://insight.jci.org/articles/view/156485/files/pdf,1,False,True
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells.,https://link.springer.com/content/pdf/10.1007/s13402-022-00718-0.pdf,1,False,True
Interleukin-10 induces expression of CD39 on CD8+T cells to potentiate anti-PD1 efficacy in EGFR-mutated non-small cell lung cancer.,https://jitc.bmj.com/content/jitc/10/12/e005436.full.pdf,1,False,True
Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor.,https://link.springer.com/content/pdf/10.1007/s11604-022-01303-z.pdf,1,False,True
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression.,https://www.nature.com/articles/s41467-022-34871-9.pdf,1,False,True
The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury.,https://www.dovepress.com/getfile.php?fileID=85536,1,False,True
The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer.,https://europepmc.org/articles/PMC9737525?pdf=render,1,True,True
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma.,https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-022-02525-9,1,False,True
Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis.,http://www.cell.com/article/S2666379122003809/pdf,1,False,True
Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1+ Tregs.,http://www.jci.org/articles/view/159925/files/pdf,1,False,True
Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF.,https://www.mdpi.com/2073-4409/11/22/3580/pdf?version=1668503478,1,False,True
Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment.,,1,False,True
DNA barcoding reveals ongoing immunoediting of clonal cancer populations during metastatic progression and immunotherapy response.,https://www.nature.com/articles/s41467-022-34041-x.pdf,1,False,True
WNK3 inhibition elicits antitumor immunity by suppressing PD-L1 expression on tumor cells and activating T-cell function.,https://www.nature.com/articles/s12276-022-00876-z.pdf,1,False,True
Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.,https://jitc.bmj.com/content/jitc/10/11/e004806.full.pdf,1,False,True
CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging.,https://www.nature.com/articles/s41593-022-01183-6.pdf,0,False,True
Dual inhibition of IDO1/TDO2 enhances anti-tumor immunity in platinum-resistant non-small cell lung cancer,https://www.researchsquare.com/article/rs-2176131/latest.pdf,0,False,True
Immunofilaments Provide a Nanoscale Platform for In Vivo T Cell Expansion and Cancer Immunotherapy,https://www.biorxiv.org/content/biorxiv/early/2022/10/18/2022.10.14.512109.full.pdf,0,False,False
"Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist.",https://jeccr.biomedcentral.com/counter/pdf/10.1186/s13046-022-02511-1,1,False,True
ALKBH5 enhances efficiency of anti-PD-1/PD-L1 therapy by reducing Lnc-XIST/miRNA- 124-3p mediated FGL1 expression in bladder cancer,https://www.researchsquare.com/article/rs-2137267/latest.pdf,0,False,True
Intracellular mRNA phase separation induced by cationic polymers for tumor immunotherapy.,https://jnanobiotechnology.biomedcentral.com/counter/pdf/10.1186/s12951-022-01647-8,1,False,True
Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy.,https://europepmc.org/articles/PMC9558691?pdf=render,1,True,True
Remodeling of the tumor microenvironment through PAK4 inhibition sensitizes tumors to immune checkpoint blockade.,https://europepmc.org/articles/PMC9799984?pdf=render,1,True,True
Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis.,https://www.nature.com/articles/s41423-022-00911-z.pdf,1,False,True
Blockade of IL-6 inhibits tumor immune evasion and improves anti-PD-1 immunotherapy.,https://www.researchsquare.com/article/rs-1420368/latest.pdf,0,False,True
USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer.,https://www.nature.com/articles/s41467-022-33285-x.pdf,1,False,True
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity.,https://europepmc.org/articles/PMC9441337?pdf=render,1,True,True
Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.,https://europepmc.org/articles/PMC9481954?pdf=render,1,True,True
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert microenvironment and is sensitized by immunogenic viruses.,http://www.jci.org/articles/view/153437/files/pdf,1,False,True
Restoration of p53 activity via intracellular protein delivery sensitizes triple negative breast cancer to anti-PD-1 immunotherapy.,https://jitc.bmj.com/content/jitc/10/9/e005068.full.pdf,1,False,True
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.,https://link.springer.com/content/pdf/10.1007/s10238-022-00878-1.pdf,0,False,True
Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis.,https://www.nature.com/articles/s41598-022-15948-3.pdf,1,False,True
Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene.,https://europepmc.org/articles/PMC9381811?pdf=render,1,True,True
Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands.,https://europepmc.org/articles/PMC9378736?pdf=render,1,True,True
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection.,https://europepmc.org/articles/PMC9844517?pdf=render,1,True,True
Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer.,https://europepmc.org/articles/PMC9357054?pdf=render,1,True,True
Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments.,https://www.researchsquare.com/article/rs-453169/v1.pdf?c=1624281047000,1,False,True
EZH2 inhibition activates dsRNA-interferon axis stress and promotes response to PD-1 checkpoint blockade in NSCLC.,https://europepmc.org/articles/PMC9330466?pdf=render,1,True,True
Antigen receptor-engineered Tregs inhibit CNS autoimmunity in cell therapy using nonredundant immune mechanisms in mice.,https://europepmc.org/articles/PMC9542066?pdf=render,1,True,True
Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors.,https://europepmc.org/articles/PMC9301046?pdf=render,1,True,True
Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment.,https://www.researchsquare.com/article/rs-142908/v1.pdf?c=1611029329000,1,False,True
PD-1 and CTLA-4 exert additive control of effector regulatory T cells,https://www.biorxiv.org/content/biorxiv/early/2022/07/22/2022.07.22.501159.full.pdf,1,False,False
"Immunohistochemistry of Immune Cells and Cells Bound to in vivo Administered Antibodies in Liver, Lung, Pancreas, and Colon of B6/lpr Mice.",https://europepmc.org/articles/PMC9350918?pdf=render,1,True,True
Myeloid mechano-metabolic programming restricts anti-tumor immunity,https://www.biorxiv.org/content/biorxiv/early/2022/08/30/2022.07.14.499764.full.pdf,0,False,False
IFNÎ± Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment.,https://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-21-1022/3112623/cd-21-1022.pdf,0,False,True
"Corrigendum to ""Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest"".",https://europepmc.org/articles/PMC9136596?pdf=render,2,True,True
Dapl1 controls NFATc2 activation to regulate CD8+ T cell exhaustion and responses in chronic infection and cancer.,https://europepmc.org/articles/PMC9704754?pdf=render,1,True,True
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.,https://jitc.bmj.com/content/jitc/10/7/e005059.full.pdf,1,False,True
Gallic acid induces T-helper-1-like Treg cells and strengthens immune checkpoint blockade efficacy.,https://jitc.bmj.com/content/jitc/10/7/e004037.full.pdf,1,False,True
Flow cytometry analysis of endothelial cells and subsets of exhausted CD8+ T cells in murine tumor models.,https://europepmc.org/articles/PMC9168162?pdf=render,1,True,True
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.,https://europepmc.org/articles/PMC9177794?pdf=render,1,True,True
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.,https://europepmc.org/articles/PMC9240938?pdf=render,1,True,True
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response.,https://europepmc.org/articles/PMC8961218?pdf=render,1,True,True
Tumor suppressor immune gene therapy to reverse immunotherapy resistance.,https://www.medrxiv.org/content/medrxiv/early/2021/01/02/2020.12.27.20248913.full.pdf,1,False,False
Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment and confers resistance to immunotherapy,https://www.biorxiv.org/content/biorxiv/early/2022/05/27/2022.05.27.493507.full.pdf,0,False,False
Peptide nano-blanket impedes fibroblasts activation and subsequent formation of pre-metastatic niche.,https://www.researchsquare.com/article/rs-699014/latest.pdf,1,False,True
A reengineered common chain cytokine augments CD8+ T cell-dependent immunotherapy.,http://insight.jci.org/articles/view/158889/files/pdf,1,False,True
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells,https://www.researchsquare.com/article/rs-1641836/latest.pdf,0,False,True
APOBEC3B Improves Response to PD-1 Blockade Through DSBs–ATR–CHK1 Pathway,https://www.researchsquare.com/article/rs-1606737/latest.pdf,0,False,True
Targeting HIF-1α abrogates PD-L1-mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues.,http://www.jci.org/articles/view/150846/files/pdf,1,False,True
Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer.,https://europepmc.org/articles/PMC9018557?pdf=render,1,True,True
FOXO3-dependent suppression of PD-L1 promotes anticancer immune responses via activation of natural killer cells.,https://europepmc.org/articles/PMC8984903?pdf=render,1,True,True
Distinct myeloid antigen-presenting cells dictate differential fates of tumor-specific CD8+ T cells in pancreatic cancer.,http://insight.jci.org/articles/view/151593/files/pdf,1,False,True
Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.,https://www.researchsquare.com/article/rs-966722/latest.pdf,1,False,True
Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy.,https://www.mdpi.com/2072-6694/14/7/1823/pdf,1,False,True
Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing.,https://www.biorxiv.org/content/biorxiv/early/2021/07/29/2021.07.29.453937.full.pdf,1,False,False
Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.,https://jitc.bmj.com/content/jitc/10/4/e004302.full.pdf,1,False,True
Inhibition of renalase drives tumour rejection by promoting T cell activation.,http://www.ejcancer.com/article/S0959804922000065/pdf,1,False,True
Plasma extracellular vesicle derived protein profile predicting and monitoring immunotherapeutic outcomes of gastric cancer.,https://europepmc.org/articles/PMC8971562?pdf=render,1,True,True
Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy.,https://europepmc.org/articles/PMC8981446?pdf=render,1,True,True
Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy.,https://europepmc.org/articles/PMC9052945?pdf=render,1,True,True
Nanoliposome C6-Ceramide in combination with anti-CTLA4 antibody improves anti-tumor immunity in hepatocellular cancer.,https://europepmc.org/articles/PMC9297193?pdf=render,1,True,True
Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria-Targeted Atovaquone.,https://europepmc.org/articles/PMC9036031?pdf=render,1,True,True
Concurrent intrathecal and intravenous nivolumab for metastatic melanoma patients with leptomeningeal disease.,https://www.researchsquare.com/article/rs-1397403/latest.pdf,0,False,True
Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity.,https://europepmc.org/articles/PMC9040180?pdf=render,1,True,True
AXL targeting restores PD-1 blockade sensitivity of STK11/LKB1 mutant NSCLC through expansion of TCF1+ CD8 T cells.,https://europepmc.org/articles/PMC9040166?pdf=render,1,True,True
Tumor-specific interendothelial adhesion mediated by FLRT2 facilitates cancer aggressiveness.,http://www.jci.org/articles/view/153626/files/pdf,1,False,True
Intratumoral Recall of Childhood Vaccine-Specific CD4sup>+/sup> T cells Coordinates Type I and II Antitumor Immunity,https://www.biorxiv.org/content/biorxiv/early/2022/03/14/2022.03.14.484260.full.pdf,0,False,False
ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.,https://europepmc.org/articles/PMC8917395?pdf=render,1,True,True
Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapy,https://www.researchsquare.com/article/rs-1420368/latest.pdf,0,False,True
PTP1B Is an Intracellular Checkpoint that Limits T-cell and CAR T-cell Antitumor Immunity.,https://www.biorxiv.org/content/biorxiv/early/2021/11/12/2021.11.11.468140.full.pdf,1,False,False
Oncolytic Orf virus licenses NK cells via cDC1 to activate innate and adaptive antitumor mechanisms and extends survival in a murine model of late-stage ovarian cancer.,https://jitc.bmj.com/content/jitc/10/3/e004335.full.pdf,1,False,True
Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy.,,1,False,True
System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma.,https://jitc.bmj.com/content/jitc/10/3/e004414.full.pdf,1,False,True
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma.,https://europepmc.org/articles/PMC8904298?pdf=render,1,True,True
Modulation of the tumor microenvironment by armed vesicular stomatitis virus in a syngeneic pancreatic cancer model.,https://virologyj.biomedcentral.com/track/pdf/10.1186/s12985-022-01757-7,1,False,True
Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer.,https://www.mdpi.com/1999-4923/14/2/440/pdf,1,False,True
"Biomimetic nanoprobe-augmented triple therapy with photothermal, sonodynamic and checkpoint blockade inhibits tumor growth and metastasis.",https://jnanobiotechnology.biomedcentral.com/track/pdf/10.1186/s12951-022-01287-y,1,False,True
Anlotinib Induces a T Cell-Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma.,https://clincancerres.aacrjournals.org/content/clincanres/early/2021/11/29/1078-0432.CCR-21-2241.full.pdf,1,False,True
Integrated Metabolic Profiling and Transcriptional Analysis Reveals Therapeutic Modalities for Targeting Rapidly Proliferating Breast Cancers.,https://europepmc.org/articles/PMC8857046?pdf=render,1,True,True
Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity.,https://europepmc.org/articles/PMC8816404?pdf=render,1,True,True
Bi-steric mTORC1-selective Inhibitors activate 4EBP1 reversing MYC-induced tumorigenesis and synergize with immunotherapy,https://www.biorxiv.org/content/biorxiv/early/2022/02/05/2022.02.04.478208.full.pdf,0,False,False
Effect of PD-1 Inhibitor Combined with X-Ray Irradiation on the Inflammatory Microenvironment and Lung Tissue Injury in Mice.,https://www.dovepress.com/getfile.php?fileID=77881,1,False,True
A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model.,https://europepmc.org/articles/PMC8804348?pdf=render,1,True,True
Remodeling Chondroitin-6-Sulfate-Mediated Immune Exclusion Enhances Anti-PD-1 Response in Colorectal Cancer with Microsatellite Stability.,https://cancerimmunolres.aacrjournals.org/content/canimm/early/2021/12/20/2326-6066.CIR-21-0124.full.pdf,1,False,True
High-Baseline Tumor Burden–Associated Macrophages Promote Immunosuppressive Microenvironment and Restrain Immune Checkpoint Inhibitor Efficacy Through the IGFBP2–STAT3–PD-L1 Pathway,https://www.researchsquare.com/article/rs-1304451/latest.pdf,0,False,True
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1.,https://helda.helsinki.fi/bitstream/10138/340033/1/Local_therapy_with_an_engineered_oncolytic_adenovirus_enables_antitumor_response_in_non_injected_melanoma_tumors_in_mice_treated_with_aPD_1.pdf,1,False,True
18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition.,https://clincancerres.aacrjournals.org/content/clincanres/early/2021/10/05/1078-0432.CCR-21-2394.full.pdf,1,False,True
Cancer cell-expressed BTNL2 facilitates tumour immune escape via engagement with IL-17A-producing γδ T cells.,https://www.nature.com/articles/s41467-021-27936-8.pdf,1,False,True
"SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models.",https://europepmc.org/articles/PMC8716998?pdf=render,1,True,True
Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by intermittent anti-PI3Kα/β/δ treatment.,https://www.nature.com/articles/s41467-021-27833-0.pdf,1,False,True
A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy.,https://europepmc.org/articles/PMC8690934?pdf=render,1,True,True
Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest.,https://www.biorxiv.org/content/biorxiv/early/2021/05/28/2021.05.27.445710.full.pdf,0,False,False
PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism.,https://www.biorxiv.org/content/biorxiv/early/2021/02/15/2020.07.14.200592.full.pdf,1,False,False
TSH-TSHR axis promotes tumor immune evasion.,https://jitc.bmj.com/content/jitc/10/1/e004049.full.pdf,3,False,True
CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.,https://jitc.bmj.com/content/jitc/10/1/e003809.full.pdf,1,False,True
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.,https://cancerdiscovery.aacrjournals.org/content/candisc/early/2021/09/03/2159-8290.CD-21-0003.full.pdf,1,False,True
Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer.,https://europepmc.org/articles/PMC8753312?pdf=render,1,True,True
Single-cell RNA sequencing to characterize the response of pancreatic cancer to anti-PD-1 immunotherapy.,https://europepmc.org/articles/PMC8591363?pdf=render,1,True,True
BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer.,https://europepmc.org/articles/PMC8792480?pdf=render,1,True,True
APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.,https://www.biorxiv.org/content/biorxiv/early/2021/02/14/2021.02.13.431068.full.pdf,1,False,False
A Novel Kinase Inhibitor AX-0085 Inhibits Interferon-γ-Mediated Induction of PD-L1 Expression and Promotes Immune Reaction to Lung Adenocarcinoma Cells.,https://europepmc.org/articles/PMC8750969?pdf=render,1,True,True
T cell-derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death.,http://insight.jci.org/articles/view/148643/files/pdf,1,False,True
"The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota.",http://www.cell.com/article/S2666379121003360/pdf,1,False,True
Targeting macrophages with CAR-T cells delays solid tumor progression and enhances anti-tumor immunity,https://www.biorxiv.org/content/biorxiv/early/2021/12/20/2021.12.17.473184.full.pdf,0,False,False
Pharmacological Activation of cGAS for Cancer Immunotherapy.,http://www.frontiersin.org/articles/10.3389/fimmu.2021.753472/pdf,4,False,True
"Alphataxin, a Small-Molecule Drug That Elevates Tumor-Infiltrating CD4+ T Cells, in Combination With Anti-PD-1 Therapy, Suppresses Murine Renal Cancer and Metastasis.",http://www.frontiersin.org/articles/10.3389/fonc.2021.739080/pdf,1,False,True
Myeloid antigen-presenting cell niches sustain antitumor TÂ cells and license PD-1 blockade via CD28 costimulation.,https://europepmc.org/articles/PMC8861565?pdf=render,1,True,True
Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis.,https://www.nature.com/articles/s41467-021-27485-0.pdf,1,False,True
Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance.,https://www.nature.com/articles/s41467-021-27349-7.pdf,1,False,True
An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.,https://jitc.bmj.com/content/jitc/9/12/e002843.full.pdf,1,False,True
Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3.,https://jitc.bmj.com/content/jitc/9/12/e002772.full.pdf,1,False,True
Tumor evolution selectively inactivates the core microRNA machinery for immune evasion.,https://www.nature.com/articles/s41467-021-27331-3.pdf,1,False,True
Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model.,https://link.springer.com/content/pdf/10.1007/s00262-021-02946-z.pdf,1,False,True
Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity.,https://www.nature.com/articles/s41598-021-02449-y.pdf,1,False,True
Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy In Patients With Unresectable Hepatocellular Carcinoma,https://www.researchsquare.com/article/rs-1078571/latest.pdf,0,False,True
Divergent fates of antigen-specific CD8+ T cell clones in mice with acute leukemia.,http://www.cell.com/article/S2211124721014704/pdf,1,False,True
SLAMF8 expression predicts the efficacy of anti-PD1 immunotherapy in gastrointestinal cancers.,https://europepmc.org/articles/PMC8546794?pdf=render,1,True,True
Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors.,https://jitc.bmj.com/content/jitc/9/11/e002970.full.pdf,1,False,True
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.,https://jitc.bmj.com/content/jitc/9/11/e002917.full.pdf,1,False,True
The Programmed Cell Death Ligand-1/Programmed Cell Death-1 Pathway Mediates Pregnancy-Induced Analgesia via Regulating Spinal Inflammatory Cytokines.,https://europepmc.org/articles/PMC8505140?pdf=render,1,True,True
Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells.,https://europepmc.org/articles/PMC8595849?pdf=render,1,True,True
Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC.,,0,False,True
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.,https://europepmc.org/articles/PMC9293411?pdf=render,1,True,True
Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 Models.,https://www.mdpi.com/1999-4923/13/11/1811/pdf,1,False,True
In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET.,https://europepmc.org/articles/PMC8554823?pdf=render,1,True,True
Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment.,https://europepmc.org/articles/pmc8539826?pdf=render,1,True,True
Effect of immune modulation on the skeletal muscle mitochondrial exercise response: An exploratory study in mice with cancer.,https://europepmc.org/articles/PMC8525738?pdf=render,1,True,True
AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway.,https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/s12943-021-01420-9,1,False,True
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.,https://europepmc.org/articles/PMC8650838?pdf=render,1,True,True
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance.,http://www.frontiersin.org/articles/10.3389/fimmu.2021.714842/pdf,1,False,True
Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity.,https://europepmc.org/articles/PMC8508526?pdf=render,1,True,True
ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming.,https://www.biorxiv.org/content/biorxiv/early/2021/08/24/2021.08.23.457444.full.pdf,1,False,False
Distinct B cell subsets in Peyer's patches convey probiotic effects by Limosilactobacillus reuteri.,https://europepmc.org/articles/PMC8487498?pdf=render,1,True,True
Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy.,https://cancerdiscovery.aacrjournals.org/content/candisc/early/2021/05/25/2159-8290.CD-20-1815.full.pdf,1,False,True
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy.,https://europepmc.org/articles/PMC8492503?pdf=render,1,True,True
Targeting of Cdc42 GTPase in regulatory T cells unleashes anti-tumor T cell immunity,https://www.biorxiv.org/content/biorxiv/early/2021/09/24/2021.09.23.461402.full.pdf,0,False,False
Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma.,https://europepmc.org/articles/PMC8433070?pdf=render,0,True,True
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation.,https://europepmc.org/articles/PMC8413837?pdf=render,1,True,True
Effector T cell responses unleashed by regulatory T cell ablation exacerbate oral squamous cell carcinoma.,https://europepmc.org/articles/PMC8484691?pdf=render,1,True,True
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.,https://europepmc.org/articles/PMC8454863?pdf=render,1,True,True
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans.,https://europepmc.org/articles/PMC8420755?pdf=render,1,True,True
Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth.,https://europepmc.org/articles/PMC8436536?pdf=render,1,True,True
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.,,1,False,True
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma.,https://europepmc.org/articles/PMC8446777?pdf=render,1,True,True
Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade.,https://europepmc.org/articles/PMC8410945?pdf=render,1,True,True
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer.,https://europepmc.org/articles/PMC8562569?pdf=render,1,True,True
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity.,https://europepmc.org/articles/PMC8408233?pdf=render,1,True,True
Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma.,https://europepmc.org/articles/PMC8383204?pdf=render,1,True,True
Dietary methionine restriction impairs anti-tumor immunity through gut microbiota,https://www.biorxiv.org/content/biorxiv/early/2021/08/30/2021.08.27.457955.full.pdf,0,False,False
Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement.,https://www.nature.com/articles/s41467-021-25391-z.pdf,1,False,True
Exosomes from primed MSCs can educate monocytes as a cellular therapy for hematopoietic acute radiation syndrome.,https://europepmc.org/articles/PMC8371870?pdf=render,1,True,True
PD-L2 based immune signature confers poor prognosis in HNSCC.,https://europepmc.org/articles/PMC8344752?pdf=render,1,True,True
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models.,https://europepmc.org/articles/PMC7612153?pdf=render,1,True,True
NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated TÂ cells.,http://www.cell.com/article/S2211124721009463/pdf,0,False,True
"VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' Prediction.",https://europepmc.org/articles/PMC8402534?pdf=render,1,True,True
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies.,https://europepmc.org/articles/PMC8331049?pdf=render,1,True,True
Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma.,https://www.medrxiv.org/content/medrxiv/early/2020/09/10/2020.09.09.20191171.full.pdf,1,False,False
CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell.,https://europepmc.org/articles/PMC8407215?pdf=render,1,True,True
Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.,https://clincancerres.aacrjournals.org/content/clincanres/27/15/4325.full.pdf,1,False,True
MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.,http://www.gastrojournal.org/article/S001650852100679X/pdf,0,False,True
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden.,https://www.biorxiv.org/content/biorxiv/early/2020/02/16/2020.02.15.950220.full.pdf,1,False,False
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma.,https://europepmc.org/articles/PMC8298272?pdf=render,1,True,True
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression.,https://www.mdpi.com/2072-6694/13/15/3733/pdf,1,False,True
Enhanced Antitumor Response to Immune Checkpoint Blockade Exerted by Cisplatin-Induced Mutagenesis in a Murine Melanoma Model.,https://europepmc.org/articles/PMC8290318?pdf=render,1,True,True
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity.,http://www.cell.com/article/S0092867421006516/pdf,1,False,True
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.,https://europepmc.org/articles/PMC8684350?pdf=render,1,True,True
Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer.,https://europepmc.org/articles/PMC8307650?pdf=render,1,True,True
Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses.,https://europepmc.org/articles/PMC8280226?pdf=render,1,True,True
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253178&type=printable,1,False,True
Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization.,https://europepmc.org/articles/PMC8261162?pdf=render,1,True,True
Explant Modeling of the Immune Environment of Head and Neck Cancer.,http://www.frontiersin.org/articles/10.3389/fonc.2021.611365/pdf,1,False,True
Leishmania Parasites Drive PD-L1 Expression in Mice and Human Neutrophils With Suppressor Capacity.,http://www.frontiersin.org/articles/10.3389/fimmu.2021.598943/pdf,1,False,True
circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation.,https://europepmc.org/articles/PMC8261519?pdf=render,1,True,True
"Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy.",,0,False,True
C4b-binding protein Î±-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.,https://jeccr.biomedcentral.com/track/pdf/10.1186/s13046-021-02019-0,1,False,True
Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells.,https://www.nature.com/articles/s41467-021-24132-6.pdf,1,False,True
Establishment of liver tumor cell lines from atherogenic and high fat diet fed hepatitis C virus transgenic mice.,https://www.nature.com/articles/s41598-021-92128-9.pdf,1,False,True
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer.,http://www.cell.com/article/S2211124721006562/pdf,1,False,True
Protocol to establish a lung adenocarcinoma immunotherapy allograft mouse model with FACS and immunofluorescence-based analysis of tumor response.,https://europepmc.org/articles/PMC8209678?pdf=render,1,True,True
Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers.,https://europepmc.org/articles/PMC8208121?pdf=render,1,True,True
PD-1 checkpoint blockade disrupts CD4 T cell regulated adaptive B cell tolerance to foreign antigens,https://www.biorxiv.org/content/biorxiv/early/2021/06/10/2021.06.10.447979.full.pdf,0,False,False
Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.,https://www.biorxiv.org/content/biorxiv/early/2020/05/21/2020.05.19.104430.full.pdf,1,False,False
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40.,https://www.nature.com/articles/s41467-021-23832-3.pdf,1,False,True
Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade.,https://europepmc.org/articles/PMC8184753?pdf=render,1,True,True
"Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.",https://www.jstage.jst.go.jp/article/bpb/44/6/44_b21-00076/_pdf,0,False,True
Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma.,https://europepmc.org/articles/PMC8231064?pdf=render,1,True,True
A Peptide-Based Checkpoint Immunomodulator Alleviates Immune Dysfunction in Murine Polymicrobial Sepsis.,https://europepmc.org/articles/PMC8284559?pdf=render,1,True,True
Qa-1b Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.,https://europepmc.org/articles/PMC8178214?pdf=render,1,True,True
Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.,https://europepmc.org/articles/PMC8113440?pdf=render,1,True,True
Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice.,https://europepmc.org/articles/PMC8486004?pdf=render,1,True,True
Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.,https://europepmc.org/articles/PMC8148423?pdf=render,1,True,True
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor TÂ cell response.,https://europepmc.org/articles/PMC8127241?pdf=render,1,True,True
Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.,https://europepmc.org/articles/PMC8141455?pdf=render,1,True,True
Prolonged activation of innate immune pathways by a polyvalent STING agonist.,https://europepmc.org/articles/PMC8126516?pdf=render,1,True,True
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity.,https://europepmc.org/articles/pmc8102376?pdf=render,1,True,True
Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy.,https://clincancerres.aacrjournals.org/content/clincanres/27/9/2481.full.pdf,1,False,True
Transient activation of tumoral DNA damage tolerance pathway coupled with immune checkpoint blockade exerts durable tumor regression in mouse melanoma.,,0,False,True
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.,https://europepmc.org/articles/PMC8062716?pdf=render,1,True,True
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response,https://www.biorxiv.org/content/biorxiv/early/2021/04/15/2021.04.14.436660.full.pdf,0,False,False
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis.,https://europepmc.org/articles/PMC8262501?pdf=render,1,True,True
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.,https://www.biorxiv.org/content/biorxiv/early/2020/05/30/2020.05.29.117531.full.pdf,1,False,False
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade,https://www.biorxiv.org/content/biorxiv/early/2021/04/11/2021.04.11.439323.full.pdf,1,False,False
PD1 blockade potentiates the therapeutic efficacy of photothermally-activated and MRI-guided low temperature-sensitive magnetoliposomes.,https://pureadmin.qub.ac.uk/ws/files/233390616/Ma_et_al_JCR_Submitted_07.02.2021.pdf,0,False,True
Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity.,https://europepmc.org/articles/PMC8050791?pdf=render,1,True,True
Decreased NSG3 enhances PD-L1 expression by Erk1/2 pathway to promote pancreatic cancer progress.,https://europepmc.org/articles/PMC7994162?pdf=render,1,True,True
Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo-Immunotherapy.,https://europepmc.org/articles/PMC8035264?pdf=render,1,True,True
Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.,https://europepmc.org/articles/PMC8011896?pdf=render,1,True,True
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH.,https://cris.maastrichtuniversity.nl/ws/files/75893375/Heeren_2021_Auto_aggressive_CXCR6_cells_cause.pdf,0,False,True
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.,https://europepmc.org/articles/PMC8046670?pdf=render,1,True,True
Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance.,https://europepmc.org/articles/PMC8283778?pdf=render,1,True,True
Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.,https://www.nature.com/articles/s41467-021-22115-1.pdf,1,False,True
Human gut microbial communities dictate efficacy of anti-PD-1 therapy in a humanized microbiome mouse model of glioma.,https://europepmc.org/articles/PMC7967908?pdf=render,1,True,True
Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.,https://www.jimmunol.org/content/jimmunol/206/6/1204.full.pdf,1,False,True
Two Novel Human Anti-cd25 Antibodies With Antitumor Activity Inversely Related to Its Affinity and in Vitro Activity,https://www.researchsquare.com/article/rs-277192/v1.pdf?c=1615609825000,0,False,True
KRAS drives immune evasion in a genetic model of pancreatic cancer.,https://europepmc.org/articles/PMC7935870?pdf=render,1,True,True
Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1.,https://europepmc.org/articles/PMC7967046?pdf=render,1,True,True
A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.,https://europepmc.org/articles/PMC7933082?pdf=render,1,True,True
"Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1.",https://www.nature.com/articles/s41416-020-01239-z.pdf,1,False,True
Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.,https://cancerdiscovery.aacrjournals.org/content/candisc/11/3/736.full.pdf,0,False,True
Bifidobacterium Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice.,https://europepmc.org/articles/PMC7956760?pdf=render,1,True,True
Novel Protein-Based Vaccine against Self-Antigen Reduces the Formation of Sporadic Colon Adenomas in Mice.,https://europepmc.org/articles/PMC7923075?pdf=render,1,True,True
CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells.,https://www.frontiersin.org/articles/10.3389/fimmu.2020.620166/pdf,1,False,True
"Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases.",https://europepmc.org/articles/PMC7865080?pdf=render,1,True,True
In Situ Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy.,https://europepmc.org/articles/PMC7918828?pdf=render,1,True,True
Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma.,https://europepmc.org/articles/PMC7854309?pdf=render,1,True,True
"Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma.",,0,False,True
Laminin γ2-mediating T cell exclusion attenuates response to anti-PD-1 therapy.,https://europepmc.org/articles/PMC7857690?pdf=render,1,True,True
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.,http://diposit.ub.edu/dspace/bitstream/2445/182708/1/nihms-1650919.pdf,1,False,True
Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity.,https://europepmc.org/articles/PMC7750418?pdf=render,1,True,True
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression.,,1,False,True
Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer.,https://jnm.snmjournals.org/content/jnumed/62/2/228.full.pdf,0,False,True
Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity.,https://europepmc.org/articles/PMC7864876?pdf=render,1,True,True
NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics.,,1,False,True
Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses.,https://europepmc.org/articles/PMC7980495?pdf=render,1,True,True
Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma.,https://europepmc.org/articles/PMC8100747?pdf=render,1,True,True
DNA barcoding reveals ongoing immunoediting of clonal cancer populations during metastatic progression and in response to immunotherapy,https://www.biorxiv.org/content/biorxiv/early/2021/01/11/2021.01.11.426174.full.pdf,0,False,False
Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer.,https://europepmc.org/articles/PMC7855651?pdf=render,1,True,True
Low STING expression in a transplantable Krassup>G12D/sup>/P53sup>ko/sup> lung cancer model contributes to SiglecFsup>+/sup> neutrophil and CD103sup>+/sup>Treg accumulation in tumors,https://www.biorxiv.org/content/biorxiv/early/2021/01/06/2021.01.04.425311.full.pdf,0,False,False
Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study.,https://europepmc.org/articles/PMC7820196?pdf=render,1,True,True
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.,https://europepmc.org/articles/PMC7785684?pdf=render,1,True,True
Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch.,https://jitc.bmj.com/content/jitc/9/1/e001932.full.pdf,1,False,True
Downregulation of Interferon-γ Receptor Expression Endows Resistance to Anti-Programmed Death Protein 1 Therapy in Colorectal Cancer.,https://jpet.aspetjournals.org/content/jpet/376/1/21.full.pdf,1,False,True
"Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies.",https://eprints.soton.ac.uk/447021/1/235697_0_merged_1579181652.pdf,0,False,True
Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy.,https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.11.978387.full.pdf,1,False,False
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model.,https://europepmc.org/articles/PMC7680263?pdf=render,1,True,True
A Quenched Annexin V-Fluorophore for the Real-Time Fluorescence Imaging of Apoptotic Processes In Vitro and In Vivo.,https://europepmc.org/articles/PMC7740095?pdf=render,1,True,True
The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients.,https://europepmc.org/articles/PMC7492992?pdf=render,1,True,True
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma.,https://europepmc.org/articles/PMC7703597?pdf=render,1,True,True
Obesity diminishes response to PD-1-based immunotherapies in renal cancer.,https://europepmc.org/articles/PMC7757487?pdf=render,1,True,True
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3.,https://europepmc.org/articles/PMC7734012?pdf=render,1,True,True
Local Targeting of NAD+ Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma.,https://europepmc.org/articles/PMC7669613?pdf=render,1,True,True
Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine.,https://europepmc.org/articles/PMC7712481?pdf=render,1,True,True
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.,https://europepmc.org/articles/PMC7647667?pdf=render,1,True,True
β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion.,https://europepmc.org/articles/PMC7596815?pdf=render,1,True,True
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse.,https://europepmc.org/articles/PMC7689071?pdf=render,1,True,True
SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.,https://europepmc.org/articles/PMC7651737?pdf=render,1,True,True
Rho-associated protein kinase-dependent moesin phosphorylation is required for PD-L1 stabilization in breast cancer.,https://europepmc.org/articles/PMC7607174?pdf=render,1,True,True
Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas.,https://europepmc.org/articles/PMC9371689?pdf=render,1,True,True
A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control.,https://europepmc.org/articles/PMC7642117?pdf=render,1,True,True
Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype.,https://europepmc.org/articles/PMC7642111?pdf=render,1,True,True
Metabolic labeling and targeted modulation of dendritic cells.,https://europepmc.org/articles/PMC7748064?pdf=render,1,True,True
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition.,https://europepmc.org/articles/PMC8074872?pdf=render,1,True,True
Id1 and PD-1 Combined Blockade Impairs Tumor Growth and Survival of KRAS-mutant Lung Cancer by Stimulating PD-L1 Expression and Tumor Infiltrating CD8+ T Cells.,https://europepmc.org/articles/PMC7693788?pdf=render,1,True,True
Angiotensin-converting enzyme (ACE) inhibitor prescription affects non-small-cell lung cancer (NSCLC) patients response to PD-1/PD-L1 immune checkpoint blockers.,https://europepmc.org/articles/PMC7595630?pdf=render,1,True,True
Calcium Channel Blocker Nifedipine Suppresses Colorectal Cancer Progression and Immune Escape by Preventing NFAT2 Nuclear Translocation.,http://www.cell.com/article/S2211124720313164/pdf,0,False,True
Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets.,https://europepmc.org/articles/PMC7606610?pdf=render,1,True,True
Overcoming resistance to immune checkpoint therapy in PTEN-null prostate cancer by sequential intermittent anti-PI3Kα/β/δ and anti-PD-1 treatment,https://www.biorxiv.org/content/biorxiv/early/2020/10/17/2020.10.17.343608.full.pdf,0,False,False
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.,https://europepmc.org/articles/PMC8053376?pdf=render,1,True,True
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.,http://www.cell.com/article/S1074761320304040/pdf,0,False,True
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer.,https://europepmc.org/articles/PMC7601245?pdf=render,1,True,True
TET2 promotes anti-tumor immunity by governing G-MDSCs and CD8+ T-cell numbers.,https://europepmc.org/articles/PMC7534639?pdf=render,1,True,True
Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis.,https://europepmc.org/articles/PMC7755924?pdf=render,1,True,True
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy.,https://europepmc.org/articles/PMC7583806?pdf=render,1,True,True
CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy.,https://europepmc.org/articles/PMC7534680?pdf=render,1,True,True
Oxysophocarpine suppresses hepatocellular carcinoma growth and sensitizes the therapeutic blockade of anti-Lag-3 via reducing FGL1 expression.,https://europepmc.org/articles/PMC7541159?pdf=render,1,True,True
Immune receptor inhibition through enforced phosphatase recruitment.,https://europepmc.org/articles/PMC7875542?pdf=render,1,True,True
Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.,https://europepmc.org/articles/PMC7592256?pdf=render,1,True,True
Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.,https://europepmc.org/articles/PMC7523356?pdf=render,1,True,True
IL-32Î³ potentiates tumor immunity in melanoma.,https://europepmc.org/articles/PMC7526542?pdf=render,4,True,True
PD-1 suppresses the maintenance of cell couples between cytotoxic T cells and target tumor cells within the tumor.,https://www.biorxiv.org/content/biorxiv/early/2018/10/16/443788.full.pdf,1,False,False
IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models.,https://europepmc.org/articles/PMC7490368?pdf=render,1,True,True
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.,https://europepmc.org/articles/PMC7526457?pdf=render,1,True,True
Harnessing Natural Killer Immunity in Metastatic SCLC.,http://www.jto.org/article/S1556086420303944/pdf,0,False,True
Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.,https://europepmc.org/articles/PMC7483850?pdf=render,1,True,True
"HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer.",https://europepmc.org/articles/PMC7484424?pdf=render,1,True,True
Sirt2 Inhibition Enhances Metabolic Fitness and Effector Functions of Tumor-Reactive T Cells.,https://europepmc.org/articles/PMC7484212?pdf=render,1,True,True
Combination Therapy with Radiation and PARP Inhibition Enhances Responsiveness to Anti-PD-1 Therapy in Colorectal Tumor Models.,https://europepmc.org/articles/PMC7416439?pdf=render,1,True,True
A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors.,https://europepmc.org/articles/PMC7483799?pdf=render,1,True,True
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses.,https://europepmc.org/articles/PMC7470186?pdf=render,0,True,True
The Third Generation Anti-HER2 Chimeric Antigen Receptor Mouse T Cells Alone or Together With Anti-PD1 Antibody Inhibits the Growth of Mouse Breast Tumor Cells Expressing HER2 in vitro and in Immune Competent Mice.,https://europepmc.org/articles/PMC7381237?pdf=render,1,True,True
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse.,http://www.cell.com/article/S1934590920302897/pdf,1,False,True
Recombinant programmed cell death 1 inhibits psoriatic inflammation in imiquimod‑treated mice.,http://www.spandidos-publications.com/10.3892/ijmm.2020.4612/download,0,False,True
Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade.,https://europepmc.org/articles/PMC7406118?pdf=render,1,True,True
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.,https://europepmc.org/articles/PMC7393498?pdf=render,1,True,True
T cell subset-selective i>IL2RA/i> enhancers shape autoimmune diabetes risk,https://www.biorxiv.org/content/biorxiv/early/2020/07/22/2020.07.22.216564.full.pdf,0,False,False
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy.,https://clincancerres.aacrjournals.org/content/clincanres/26/14/3831.full.pdf,0,False,True
PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity.,https://europepmc.org/articles/PMC7508354?pdf=render,1,True,True
Absence of central tolerance in Aire-deficient mice synergizes with immune-checkpoint inhibition to enhance antitumor responses.,https://europepmc.org/articles/PMC7343867?pdf=render,1,True,True
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy.,https://link.springer.com/content/pdf/10.1007/s00262-020-02534-7.pdf,1,False,True
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models.,https://stm.sciencemag.org/content/scitransmed/12/550/eaaz7252.full.pdf,1,False,True
In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2.,https://europepmc.org/articles/PMC7210382?pdf=render,1,True,True
Oncolytic virus-derived type I interferon restricts CAR T cell therapy.,https://europepmc.org/articles/PMC7314766?pdf=render,1,True,True
PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer.,https://europepmc.org/articles/PMC7350208?pdf=render,1,True,True
CD279 mediates the homeostasis and survival of regulatory T cells by enhancing T cell and macrophage interactions.,https://europepmc.org/articles/PMC7262947?pdf=render,1,True,True
Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma.,https://europepmc.org/articles/PMC7325120?pdf=render,1,True,True
"High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma.",https://www.biorxiv.org/content/biorxiv/early/2019/12/12/2019.12.12.874198.full.pdf,1,False,False
ACKR4 restrains antitumor immunity by regulating CCL21.,https://rupress.org/jem/article-pdf/217/6/e20190634/1175876/jem_20190634.pdf,0,False,True
SHP2 Inhibition Abrogates Adaptive Resistance to KRASsup>G12C/sup>-Inhibition and Remodels the Tumor Microenvironment of i>KRAS/i>-Mutant Tumors,https://www.biorxiv.org/content/biorxiv/early/2020/05/31/2020.05.30.125138.full.pdf,0,False,False
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.,http://www.cell.com/article/S1074761320300893/pdf,0,False,True
Cancer Cell Intrinsic Expression of MHCII Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma,https://www.biorxiv.org/content/biorxiv/early/2020/05/12/2020.01.09.900597.full.pdf,1,False,False
FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer.,https://europepmc.org/articles/PMC7190812?pdf=render,1,True,True
Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma.,http://www.cell.com/article/S1535610820301562/pdf,0,False,True
Effective combinatorial immunotherapy for penile squamous cell carcinoma.,https://europepmc.org/articles/PMC7195486?pdf=render,2,True,True
Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.,https://europepmc.org/articles/PMC7296553?pdf=render,1,True,True
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy.,https://europepmc.org/articles/PMC7190922?pdf=render,1,True,True
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapy.,https://www.biorxiv.org/content/biorxiv/early/2019/08/06/727826.full.pdf,1,False,False
Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade.,,0,False,True
The Injury Response to DNA Damage Promotes Anti-Tumor Immunity,https://www.biorxiv.org/content/biorxiv/early/2020/04/27/2020.04.26.062216.full.pdf,1,False,False
Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.,https://www.biorxiv.org/content/biorxiv/early/2019/01/22/526343.full.pdf,1,False,False
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.,https://europepmc.org/articles/PMC7278897?pdf=render,1,True,True
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.,https://europepmc.org/articles/PMC7472648?pdf=render,0,True,True
Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer.,https://europepmc.org/articles/PMC7108920?pdf=render,1,True,True
PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors.,,0,False,True
Therapy With Carboplatin and Anti-PD-1 Antibodies Before Surgery Demonstrates Sustainable Anti-Tumor Effects for Secondary Cancers in Mice With Triple-Negative Breast Cancer.,https://europepmc.org/articles/PMC7066228?pdf=render,1,True,True
Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression.,http://www.cell.com/article/S0092867420302191/pdf,1,False,True
Influence on [18F]FDG uptake by cancer cells after anti-PD-1 therapy in an enforced-immune activated mouse tumor.,https://europepmc.org/articles/PMC7080890?pdf=render,1,True,True
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.,http://www.cell.com/article/S1535610820300957/pdf,0,False,True
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.,https://europepmc.org/articles/PMC7181337?pdf=render,1,True,True
4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers.,https://europepmc.org/articles/PMC7073290?pdf=render,1,True,True
Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicity.,https://europepmc.org/articles/PMC7141404?pdf=render,1,True,True
Meningeal lymphatic vessels regulate brain tumor drainage and immunity.,https://europepmc.org/articles/PMC7054407?pdf=render,1,True,True
Antibody Opsonization of a TLR9 Agonist-Containing Virus-like Particle Enhances In Situ Immunization.,https://europepmc.org/articles/PMC7033003?pdf=render,1,True,True
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma.,https://europepmc.org/articles/PMC7015935?pdf=render,1,True,True
APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.,https://europepmc.org/articles/PMC7005822?pdf=render,1,True,True
Sub-acute Toxicity in Non-cancerous Tissue and Immune-Related Adverse Events of a Novel Combination Therapy for Cancer.,https://europepmc.org/articles/PMC6971197?pdf=render,1,True,True
Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model.,https://europepmc.org/articles/PMC6971044?pdf=render,1,True,True
Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors.,https://europepmc.org/articles/PMC6992734?pdf=render,1,True,True
Exercise reduces immune suppression and breast cancer progression in a preclinical model.,https://europepmc.org/articles/PMC6996907?pdf=render,1,True,True
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.,https://europepmc.org/articles/PMC6978345?pdf=render,1,True,True
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model.,https://europepmc.org/articles/PMC6983418?pdf=render,1,True,True
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.,https://europepmc.org/articles/PMC7000961?pdf=render,1,True,True
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade.,https://stm.sciencemag.org/content/scitransmed/12/526/eaax7992.full.pdf,0,False,True
FOXD3 Regulates VISTA Expression in Melanoma.,https://europepmc.org/articles/PMC6995351?pdf=render,0,True,True
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas.,https://europepmc.org/articles/PMC6969504?pdf=render,1,True,True
Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance.,http://www.cell.com/article/S1535610819305732/pdf,1,False,True
Repurposing the yellow fever vaccine for intratumoral immunotherapy.,https://europepmc.org/articles/PMC6949490?pdf=render,1,True,True
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity.,https://europepmc.org/articles/PMC7183328?pdf=render,2,True,True
U3-1402 sensitizes HER3-expressing tumors to PD-1 blockade by immune activation.,http://www.jci.org/articles/view/126598/files/pdf,1,False,True
"Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.",https://clincancerres.aacrjournals.org/content/clincanres/26/1/290.full.pdf,1,False,True
PAK4 inhibition improves PD-1 blockade immunotherapy.,,2,False,True
VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours.,https://europepmc.org/articles/PMC7100608?pdf=render,1,True,True
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.,https://europepmc.org/articles/PMC7182038?pdf=render,1,True,True
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load.,https://europepmc.org/articles/PMC6937231?pdf=render,1,True,True
PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways.,https://www.biorxiv.org/content/biorxiv/early/2019/04/21/615138.full.pdf,1,False,False
Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.,http://europepmc.org/articles/PMC6895448?pdf=render,1,True,True
Creatine uptake regulates CD8 T cell antitumor immunity.,http://europepmc.org/articles/PMC6888972?pdf=render,1,True,True
Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.,,0,False,True
Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.,https://europepmc.org/articles/PMC6966619?pdf=render,1,True,True
MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer.,https://europepmc.org/articles/PMC6881545?pdf=render,1,True,True
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.,https://europepmc.org/articles/PMC6939458?pdf=render,1,True,True
Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME).,http://europepmc.org/articles/PMC6839078?pdf=render,1,True,True
PD-1 inhibitors dependent CD8+ T cells inhibit mouse colon cancer cell metastasis.,http://europepmc.org/articles/PMC6717878?pdf=render,1,True,True
Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma.,https://europepmc.org/articles/PMC6945240?pdf=render,1,True,True
Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer.,https://europepmc.org/articles/PMC7017719?pdf=render,1,True,True
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.32531,1,False,True
Chemotherapy induced immunogenic cell death alters response to exogenous activation of STING pathway and PD-L1 immune checkpoint blockade in a syngeneic murine model of ovarian cancer,https://www.biorxiv.org/content/biorxiv/early/2019/10/30/824094.full.pdf,0,False,False
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.,http://europepmc.org/articles/PMC6819555?pdf=render,1,True,True
Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression.,https://europepmc.org/articles/PMC6781002?pdf=render,1,True,True
The efficacy of third generation anti‑HER2 chimeric antigen receptor T cells in combination with PD1 blockade against malignant glioblastoma cells.,http://www.spandidos-publications.com/10.3892/or.2019.7263/download,0,False,True
Role of CXCR3 signaling in response to anti-PD-1 therapy.,http://europepmc.org/articles/PMC6838359?pdf=render,1,True,True
Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.,,0,False,True
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment.,https://europepmc.org/articles/PMC6814262?pdf=render,1,True,True
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer.,http://europepmc.org/articles/PMC6749627?pdf=render,1,True,True
Immunotherapy with Monoclonal Antibodies in Lung Cancer of Mice: Oxidative Stress and Other Biological Events.,https://www.preprints.org/manuscript/201906.0080/v1/download,1,False,True
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response.,http://europepmc.org/articles/PMC6702967?pdf=render,1,True,True
Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer.,https://www.biorxiv.org/content/biorxiv/early/2019/06/14/671198.1.full.pdf,1,False,False
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence.,http://europepmc.org/articles/PMC6702226?pdf=render,1,True,True
Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma.,http://www.cell.com/article/S2211124719309635/pdf,1,False,True
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity.,http://europepmc.org/articles/PMC6889821?pdf=render,1,True,True
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.,http://www.cell.com/article/S1535610819303009/pdf,1,False,True
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade.,https://europepmc.org/articles/PMC6830508?pdf=render,1,True,True
Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.,https://europepmc.org/articles/PMC6662630?pdf=render,1,True,True
Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice.,http://repositori.upf.edu/bitstream/10230/43516/1/salazar-jcp-redu.pdf,0,False,True
Protection induced by anti-PD-1 and anti-PD-L1 treatment ini>Leishmania amazonensis/i>-infected BALB/c mice,https://www.biorxiv.org/content/biorxiv/early/2019/08/01/721894.full.pdf,0,False,False
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma.,https://europepmc.org/articles/PMC6677618?pdf=render,1,True,True
Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1.,http://europepmc.org/articles/PMC6659631?pdf=render,1,True,True
Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.,http://europepmc.org/articles/PMC6637574?pdf=render,1,True,True
Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy.,https://europepmc.org/articles/PMC6606349?pdf=render,1,True,True
Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy.,https://europepmc.org/articles/PMC6748621?pdf=render,1,True,True
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.,https://europepmc.org/articles/PMC6831211?pdf=render,1,True,True
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade.,http://europepmc.org/articles/PMC6584502?pdf=render,1,True,True
A landmark in drug discovery based on complex natural product synthesis.,http://europepmc.org/articles/PMC6572832?pdf=render,1,True,True
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy.,http://europepmc.org/articles/PMC6559950?pdf=render,1,True,True
Activation of Mevalonate Pathway via LKB1 Is Essential for Stability of Treg Cells.,http://www.cell.com/article/S221112471930631X/pdf,0,False,True
Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2).,http://www.jci.org/articles/view/127755/files/pdf,0,False,True
MicroRNA-155 Expression Is Enhanced by T-cell Receptor Stimulation Strength and Correlates with Improved Tumor Control in Melanoma.,,0,False,True
Light-sheet microscopy in the near-infrared II window.,http://europepmc.org/articles/PMC6579541?pdf=render,1,True,True
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC.,https://www.biorxiv.org/content/biorxiv/early/2019/01/27/531236.full.pdf,1,False,False
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.,http://europepmc.org/articles/PMC6531311?pdf=render,1,True,True
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.,http://www.cell.com/article/S2211124719305716/pdf,0,False,True
LNK suppresses interferon signaling in melanoma.,http://europepmc.org/articles/PMC6527565?pdf=render,0,True,True
Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation.,http://europepmc.org/articles/PMC6521897?pdf=render,1,True,True
MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.,https://europepmc.org/articles/PMC6904924?pdf=render,1,True,True
Pathology of spontaneous and immunotherapy-induced tumor regression in a murine model of melanoma.,https://europepmc.org/articles/PMC6500596?pdf=render,1,True,True
Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.,https://dadun.unav.edu/bitstream/10171/62378/1/s41586-019-1162-y.pdf,0,False,True
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells.,http://europepmc.org/articles/PMC6467894?pdf=render,1,True,True
Pulsatile MEK Inhibition Improves Anti-tumor Immunity and T Cell Function in Murine Kras Mutant Lung Cancer.,http://www.cell.com/article/S2211124719303961/pdf,1,False,True
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.,https://europepmc.org/articles/PMC6467776?pdf=render,1,True,True
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.,http://europepmc.org/articles/PMC6454603?pdf=render,1,True,True
Radiotherapy and Cisplatin Increase Immunotherapy Efficacy by Enabling Local and Systemic Intratumoral T-cell Activity.,https://www.biorxiv.org/content/biorxiv/early/2018/06/29/357533.full.pdf,0,False,False
IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma.,http://www.jci.org/articles/view/124077/files/pdf,1,False,True
Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma.,https://europepmc.org/articles/pmc6420873?pdf=render,1,True,True
TGFÎ² Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer.,https://europepmc.org/articles/PMC6397698?pdf=render,1,True,True
Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung Cancer.,http://jpet.aspetjournals.org/content/jpet/368/3/401.full.pdf,0,False,True
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.,https://europepmc.org/articles/PMC6402974?pdf=render,0,True,True
Endoplasmic Reticulum Stress Contributes to Mitochondrial Exhaustion of CD8+ T Cells.,https://europepmc.org/articles/PMC6397687?pdf=render,1,True,True
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.,https://europepmc.org/articles/PMC6886475?pdf=render,1,True,True
Adenovirus based virus-like-vaccines targeting endogenous retroviruses can eliminate growing colorectal cancers in mice.,http://europepmc.org/articles/PMC6402721?pdf=render,1,True,True
Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.,http://europepmc.org/articles/PMC6365524?pdf=render,1,True,True
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity.,https://europepmc.org/articles/PMC6343772?pdf=render,1,True,True
Dynamic metrics-based biomarkers to predict responders to anti-PD-1 immunotherapy.,https://europepmc.org/articles/PMC6353899?pdf=render,1,True,True
Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response.,https://clincancerres.aacrjournals.org/content/clincanres/25/3/1036.full.pdf,1,False,True
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.,http://europepmc.org/articles/PMC6347724?pdf=render,1,True,True
Bone marrow transplantation generates T cell-dependent control of myeloma in mice.,http://europepmc.org/articles/PMC6307976?pdf=render,1,True,True
"Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.",http://europepmc.org/articles/PMC6299665?pdf=render,1,True,True
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.,http://www.cell.com/article/S0092867418313229/pdf,1,False,True
Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.,http://www.cell.com/article/S2211124718318102/pdf,0,False,True
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy.,http://europepmc.org/articles/PMC6328025?pdf=render,1,True,True
Protective Epitope Discovery and Design of MUC1-based Vaccine for Effective Tumor Protections in Immunotolerant Mice.,http://europepmc.org/articles/PMC6470043?pdf=render,1,True,True
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes.,http://europepmc.org/articles/PMC6281604?pdf=render,1,True,True
Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy.,http://europepmc.org/articles/PMC6199861?pdf=render,1,True,True
Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer.,http://europepmc.org/articles/PMC6209395?pdf=render,1,True,True
Single-Cell Modeling of CD8sup>+/sup> T Cell Exhaustion Predicts Response to Cancer Immunotherapy,https://www.biorxiv.org/content/biorxiv/early/2018/11/02/459867.full.pdf,0,False,False
Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer.,https://cancerimmunolres.aacrjournals.org/content/canimm/6/11/1426.full.pdf,0,False,True
Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy.,,0,False,True
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.,http://europepmc.org/articles/PMC6641984?pdf=render,1,True,True
Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor.,http://europepmc.org/articles/PMC6169574?pdf=render,1,True,True
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade.,http://www.cell.com/article/S1525001618303381/pdf,1,False,True
Tumor Regression and Cure Depends on Sustained Th1 Responses.,http://europepmc.org/articles/PMC6133214?pdf=render,1,True,True
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies.,http://europepmc.org/articles/PMC6204801?pdf=render,1,True,True
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.,https://europepmc.org/articles/PMC6126939?pdf=render,1,True,True
Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.,,0,False,True
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.,http://europepmc.org/articles/PMC6524525?pdf=render,1,True,True
Enhancing immunotherapy of STING agonist for lymphoma in preclinical models.,http://europepmc.org/articles/PMC6134215?pdf=render,1,True,True
IL35 Hinders Endogenous Antitumor T-cell Immunity and Responsiveness to Immunotherapy in Pancreatic Cancer.,https://europepmc.org/articles/PMC6125203?pdf=render,1,True,True
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.,https://europepmc.org/articles/PMC6129206?pdf=render,1,True,True
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes.,http://europepmc.org/articles/PMC6109072?pdf=render,1,True,True
IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to Immunotherapy.,http://www.cell.com/article/S2405471218302382/pdf,0,False,True
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.,https://europepmc.org/articles/PMC6707727?pdf=render,0,True,True
Non-conventional Inhibitory CD4+Foxp3-PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity.,http://www.cell.com/article/S153561081830223X/pdf,1,False,True
Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.,http://europepmc.org/articles/PMC5993601?pdf=render,1,True,True
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell-Driven Antitumor Immunity.,http://europepmc.org/articles/PMC5959006?pdf=render,1,True,True
Termination of T cell priming relies on a phase of unresponsiveness promoting disengagement from APCs and T cell division.,http://europepmc.org/articles/PMC5940264?pdf=render,1,True,True
Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.,https://clincancerres.aacrjournals.org/content/clincanres/24/9/2171.full.pdf,0,False,True
Blockade of Tumor-Expressed PD-1 promotes lung cancer growth.,http://europepmc.org/articles/PMC5889288?pdf=render,1,True,True
Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment.,http://www.cell.com/article/S1550413118301177/pdf,0,False,True
Impact of Chemical-Induced Mutational Load Increase on Immune Checkpoint Therapy in Poorly Responsive Murine Tumors.,,0,False,True
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity.,http://europepmc.org/articles/PMC5839760?pdf=render,0,True,True
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.,http://www.cell.com/article/S0092867417315064/pdf,1,False,True
Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade.,http://europepmc.org/articles/PMC5790382?pdf=render,1,True,True
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.,http://europepmc.org/articles/PMC5909977?pdf=render,1,True,True
Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.,http://europepmc.org/articles/PMC5809290?pdf=render,1,True,True
Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade.,https://www.biorxiv.org/content/biorxiv/early/2017/06/06/146498.full.pdf,1,False,False
"Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer.",,0,False,True
TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.,http://europepmc.org/articles/PMC5764109?pdf=render,1,True,True
T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.,http://europepmc.org/articles/PMC5739580?pdf=render,1,True,True
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.,http://stm.sciencemag.org/content/scitransmed/10/422/eaam7577.full.pdf,1,False,True
HDAC inhibition potentiates immunotherapy in triple negative breast cancer.,http://europepmc.org/articles/PMC5768393?pdf=render,1,True,True
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.,http://europepmc.org/articles/PMC5734932?pdf=render,1,True,True
PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis.,http://europepmc.org/articles/PMC5821214?pdf=render,1,True,True
Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma.,http://europepmc.org/articles/PMC5712281?pdf=render,1,True,True
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.,http://europepmc.org/articles/PMC5718941?pdf=render,1,True,True
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.,http://europepmc.org/articles/PMC5808406?pdf=render,1,True,True
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness.,http://www.cell.com/article/S1074761317304636/pdf,0,False,True
Co-targeting aurora kinase with PD-L1 and PI3K abrogates immune checkpoint mediated proliferation in peripheral T-cell lymphoma: a novel therapeutic strategy.,http://europepmc.org/articles/PMC5725023?pdf=render,1,True,True
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.,http://europepmc.org/articles/PMC5691891?pdf=render,1,True,True
PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD2 antibody ch14.18/CHO.,http://europepmc.org/articles/PMC5665083?pdf=render,1,True,True
Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade.,http://europepmc.org/articles/PMC5665063?pdf=render,1,True,True
Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade.,http://europepmc.org/articles/PMC5682963?pdf=render,1,True,True
Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence.,https://europepmc.org/articles/PMC5858196?pdf=render,1,True,True
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.,http://www.cell.com/article/S1074761317304235/pdf,0,False,True
"CBP501 induces immunogenic tumor cell death and CD8 T cell infiltration into tumors in combination with platinum, and increases the efficacy of immune checkpoint inhibitors against tumors in mice.",http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=20968&path%5B%5D=66779,1,False,True
Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells.,http://europepmc.org/articles/PMC5601925?pdf=render,1,True,True
Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.,https://www.nature.com/articles/s41467-017-00530-7.pdf,1,False,True
NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer.,http://europepmc.org/articles/PMC5633372?pdf=render,1,True,True
The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.,http://europepmc.org/articles/PMC5787226?pdf=render,1,True,True
Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms.,http://europepmc.org/articles/PMC5570934?pdf=render,1,True,True
Commensal bacterial modulation of the host immune response to ameliorate pain in a murine model of chronic prostatitis.,http://europepmc.org/articles/PMC6019276?pdf=render,1,True,True
Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells.,http://europepmc.org/articles/PMC5520051?pdf=render,1,True,True
Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition.,http://europepmc.org/articles/PMC5486174?pdf=render,1,True,True
PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1.,http://europepmc.org/articles/PMC5831162?pdf=render,1,True,True
A STING-activating nanovaccine for cancer immunotherapy.,http://europepmc.org/articles/PMC5500418?pdf=render,1,True,True
Blockade of only TGF-Î² 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.,http://europepmc.org/articles/PMC5467996?pdf=render,1,True,True
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.,http://europepmc.org/articles/PMC5472757?pdf=render,1,True,True
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses.,http://europepmc.org/articles/PMC5460993?pdf=render,1,True,True
PD-1 regulates KLRG1+ group 2 innate lymphoid cells.,http://europepmc.org/articles/PMC5461001?pdf=render,2,True,True
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models.,http://europepmc.org/articles/PMC5443787?pdf=render,1,True,True
Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.,https://europepmc.org/articles/PMC5474226?pdf=render,1,True,True
Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy.,http://europepmc.org/articles/PMC5383647?pdf=render,1,True,True
Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.,http://europepmc.org/articles/PMC5383577?pdf=render,1,True,True
Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression.,http://mct.aacrjournals.org/content/16/4/671.full.pdf,0,False,True
Designer vaccine nanodiscs for personalized cancer immunotherapy.,http://europepmc.org/articles/PMC5374005?pdf=render,0,True,True
Effective combinatorial immunotherapy for castration-resistant prostate cancer.,http://europepmc.org/articles/PMC5374023?pdf=render,0,True,True
Priming is key to effective incorporation of image-guided thermal ablation into immunotherapy protocols.,http://europepmc.org/articles/PMC5358490?pdf=render,1,True,True
"Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer.",http://europepmc.org/articles/PMC5373378?pdf=render,1,True,True
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy.,http://europepmc.org/articles/PMC5330718?pdf=render,1,True,True
"Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer.",http://europepmc.org/articles/PMC5283642?pdf=render,1,True,True
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.,http://europepmc.org/articles/PMC5215252?pdf=render,1,True,True
Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade.,http://europepmc.org/articles/PMC5214950?pdf=render,0,True,True
Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment.,http://europepmc.org/articles/PMC5286917?pdf=render,1,True,True
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease.,,0,False,True
IAP antagonists induce anti-tumor immunity in multiple myeloma.,http://europepmc.org/articles/PMC5515246?pdf=render,0,True,True
"Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.",http://cancerimmunolres.aacrjournals.org/content/canimm/4/10/845.full.pdf,1,False,True
Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.,http://europepmc.org/articles/PMC5061503?pdf=render,1,True,True
Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer.,,0,False,True
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.,http://europepmc.org/articles/PMC5026128?pdf=render,1,True,True
Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.,http://europepmc.org/articles/PMC4992661?pdf=render,1,True,True
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.,http://europepmc.org/articles/PMC4935930?pdf=render,1,True,True
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma.,http://clincancerres.aacrjournals.org/content/22/15/3849.full.pdf,0,False,True
TGF-Î² and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies.,http://europepmc.org/articles/PMC5033816?pdf=render,1,True,True
Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma.,http://cancerimmunolres.aacrjournals.org/content/canimm/4/6/531.full.pdf,1,False,True
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma.,http://link.springer.com/content/pdf/10.1007%2Fs00262-016-1843-4.pdf,1,False,True
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.,http://europepmc.org/articles/PMC4864933?pdf=render,1,True,True
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression.,http://europepmc.org/articles/PMC4826807?pdf=render,1,True,True
"Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors.",http://europepmc.org/articles/PMC4856741?pdf=render,0,True,True
Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models.,http://europepmc.org/articles/PMC4674486?pdf=render,1,True,True
Immunosurveillance and therapy of multiple myeloma are CD226 dependent.,http://www.jci.org/articles/view/77181/files/pdf,1,False,True
Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies.,http://europepmc.org/articles/PMC4336234?pdf=render,1,True,True
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity.,http://doc.rero.ch/record/326438/files/262_2014_Article_1565.pdf,0,False,True
Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity by stimulation of dendritic cells.,http://cancerimmunolres.aacrjournals.org/content/2/8/741.full.pdf,0,False,True
Immune cell-poor melanomas benefit from PD-1 blockade after targeted type I IFN activation.,http://cancerdiscovery.aacrjournals.org/content/4/6/674.full.pdf,0,False,True
Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs.,http://europepmc.org/articles/PMC4104995?pdf=render,1,True,True
Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.,http://europepmc.org/articles/PMC4283993?pdf=render,1,True,True
"Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.",http://europepmc.org/articles/PMC3698523?pdf=render,1,True,True
Long-lasting complete regression of established mouse tumors by counteracting Th2 inflammation.,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685275/pdf/,1,False,True
Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.,http://europepmc.org/articles/PMC3548961?pdf=render,0,True,True
Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients.,http://europepmc.org/articles/PMC3382903?pdf=render,1,True,True
